Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide is a synthetic small molecule belonging to the indolecarboxamides class. It features a unique structure with bromine, sulfonyl, and carboxamide functional groups attached to an indole core. This compound has been investigated in pharmacological research for its potential biological activities, particularly in oncology and inflammatory diseases. Its mechanism of action is believed to involve interaction with various molecular targets such as kinases and proteins involved in cell signaling pathways; however, the precise targets remain undefined. The compound is considered experimental and has not been approved for clinical use[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide.